Cargando…

A cost-effectiveness analysis of caspofungin vs. liposomal amphotericin B for treatment of suspected fungal infections in the UK

OBJECTIVE: To evaluate the cost-effectiveness of caspofungin vs. liposomal amphotericin B in the treatment of suspected fungal infections in the UK. METHODS: The cost-effectiveness of caspofungin vs. liposomal amphotericin B was evaluated using a decision-tree model. The decision tree was populated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bruynesteyn, Karin, Gant, Vanya, McKenzie, Catherine, Pagliuca, Tony, Poynton, Chris, Kumar, Ritesh N, Jansen, Jeroen P
Formato:	Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2007
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1974808/ https://www.ncbi.nlm.nih.gov/pubmed/17419744 http://dx.doi.org/10.1111/j.1600-0609.2007.00850.x

Ejemplares similares

Economic evaluation of caspofungin vs liposomal amphotericin B for empirical therapy of suspected systemic fungal infection in the German hospital setting
por: Kaskel, Peter, et al.
Publicado: (2007)

Combination of amphotericin B and caspofungin in the treatment of mucormycosis
por: Gargouri, Marwa, et al.
Publicado: (2019)

Application of caspofungin in China compared with amphotericin B and fluconazole
por: Zhang, Chunyu, et al.
Publicado: (2014)

Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey
por: Turner, Stuart J, et al.
Publicado: (2013)

Vertebral infection with Candida albicans failing caspofungin and fluconazole combination therapy but successfully treated with high dose liposomal amphotericin B and flucytosine
por: Storm, Line, et al.
Publicado: (2014)

Susceptibility testing of Candida albicans isolated from oropharyngeal mucosa of HIV(+) patients to fluconazole, amphotericin B and Caspofungin. killing kinetics of caspofungin and amphotericin B against fluconazole resistant and susceptible isolates
por: de Aquino Lemos, Janine, et al.
Publicado: (2009)

Evaluation of Liposomal and Conventional Amphotericin B in Experimental Fungal Keratitis Rabbit Model
por: Ghosh, Anup Kumar, et al.
Publicado: (2019)

Liposomal amphotericin B—the present
por: Maertens, J, et al.
Publicado: (2022)

Liposomal amphotericin B—the past
por: Brüggemann, R J, et al.
Publicado: (2022)

Liposomal amphotericin B—the future
por: Hoenigl, M, et al.
Publicado: (2022)

In Vitro Interaction and Killing-Kinetics of Amphotericin B Combined with Anidulafungin or Caspofungin against Candida auris
por: Caballero, Unai, et al.
Publicado: (2021)

Liposomal Amphotericin B Treatment and the Leishmaniases
por: Berman, Jonathan
Publicado: (2019)

Successful management of recalcitrant fungal keratitis with topical caspofungin
por: Goel, Siddhi, et al.
Publicado: (2022)

Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients
por: Miceli, Marisa H, et al.
Publicado: (2012)

Evaluation of liposomal amphotericin B for the treatment of fungal keratitis in a tertiary eye care hospital
por: Kumar, Vishal, et al.
Publicado: (2023)

Amphotericin-B/amphotericin-B-liposomal: Lack of efficacy: 2 case reports
Publicado: (2022)

Economic impact of treating invasive mold disease with isavuconazole compared with liposomal amphotericin B in the UK
por: Bagshaw, Emma, et al.
Publicado: (2018)

Outpatient parenteral antifungal therapy (OPAT) for invasive fungal infections with intermittent dosing of liposomal amphotericin B
por: van de Peppel, Robert J, et al.
Publicado: (2020)

Liposomal Amphotericin B and Leishmaniasis: Dose and Response
por: Sundar, Shyam, et al.
Publicado: (2010)

Amphotericin-B-liposomal: No improvement: case report
Publicado: (2022)

Amphotericin-B-liposomal: Anaphylaxis: case report
Publicado: (2022)

Fungal Keratitis Caused by Candida orthopsilosis Successfully Treated with Caspofungin
por: Kim, Tae Hwan, et al.
Publicado: (2020)

Pharmacology of Liposomal Amphotericin B: An Introduction to Preclinical and Clinical Advances for Treatment of Life-threatening Invasive Fungal Infections
por: Walsh, Thomas J, et al.
Publicado: (2019)

Multifaceted efficacy of caspofungin against fungal infections in COVID-19 patients
por: Itoh, Kazuhiro, et al.
Publicado: (2022)

Liposomal amphotericin B as a treatment for human leishmaniasis
por: Balasegaram, Manica, et al.
Publicado: (2012)

Treatment of Complex Cutaneous Leishmaniasis with Liposomal Amphotericin B
por: Ubals, Maria, et al.
Publicado: (2021)

In vitro susceptibility to amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin of Aspergillus spp. isolated from patients with haematological malignancies in Tunisia
por: Gheith, Soukeina, et al.
Publicado: (2014)

In vitro activities of amphotericin B deoxycholate and liposomal amphotericin B against 604 clinical yeast isolates
por: Montagna, Maria Teresa, et al.
Publicado: (2014)

Combination liposomal amphotericin B, posaconazole and oral amphotericin B for treatment of gastrointestinal Mucorales in an immunocompromised patient
por: Anderson, Anthony, et al.
Publicado: (2017)

845. Clinical Outcomes in Patients Treated with High vs. Standard Dose Liposomal Amphotericin B for Invasive Mucormycosis
por: Valiante, Sarah, et al.
Publicado: (2023)

1955. A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin vs. Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants ≤3 Months of Age
por: Kim, Jason, et al.
Publicado: (2018)

Caspofungin for the Treatment of Immunocompromised and Severely Ill Children and Neonates with Invasive Fungal Infections
por: Wiederhold, Nathan P., et al.
Publicado: (2012)

Voriconazole plus caspofungin for treatment of invasive fungal infection in children with acute leukemia
por: Lee, Kyu Ho, et al.
Publicado: (2017)

Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B
por: Morizot, Gloria, et al.
Publicado: (2016)

Amphotericin B liposome-induced acrocyanosis and elevated serum creatinine
por: Zhang, Xiangcai, et al.
Publicado: (2016)

Unveiling the Synergistic Interaction Between Liposomal Amphotericin B and Colistin
por: Teixeira-Santos, Rita, et al.
Publicado: (2016)

Successful treatment of cutaneous protothecosis with liposomal amphotericin and oral itraconazole
por: McMullan, Brendan, et al.
Publicado: (2016)

Renal Recovery following Liposomal Amphotericin B-Induced Nephrotoxicity
por: Personett, Heather A., et al.
Publicado: (2019)

Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B
por: Groll, Andreas H, et al.
Publicado: (2019)

Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis
por: Jarvis, Joseph N, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jc6ch5vl83usk1da1qk6vecimo